# NB_structural_variants

## Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma
Gonzalo Lopez<sup>1,2+</sup>, Karina L. Conkrite1,3+, Miriam Doepner1,3, Komal S. Rathi4, Apexa Modi1,3,11, 
Zalman Vaksman1,3,4, Lance M. Farra1,3, Eric Hyson1,3, Moataz Noureddine1,3, Jun S. Wei5, Malcolm A. Smith10, Shahab Asgharzadeh6,7, Robert C. Seeger6,7, Javed Khan5, Jaime Guidry Auvil9, Daniela S. Gerhard9, John M. Maris1,3,11,12, Sharon J. Diskin1,3,4,10,11*

1Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA.

2 Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

3Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA.

4Department of Biomedical and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA.

5Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

6Division of Hematology, Oncology and Blood and Marrow Transplantation, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.

7The Saban Research Institute, Children’s Hospital of Los Angeles, Los Angeles, CA, USA.

8Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

9Office of Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.

10Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA.

11Genomics and Computational Biology, Biomedical Graduate Studies, Perelman School of
     Medicine, University of Pennsylvania, Philadelphia, PA, USA.

12Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
